Association of MITF and other melanosome-related proteins with chemoresistance in melanoma tumors and cell lines

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Melanoma research

• Publication date

  2013-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/CMR.0b013e328362f9cdPMID 23921446
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of coding region determinant binding protein sensitizes melanoma cells to chemotherapeutic agents

  2012cited by this paper
• Improved survival with vemurafenib in melanoma with BRAF V600E mutation.

  2011cited by this paper
• Targeting protein-trafficking pathways alters melanoma treatment sensitivity

  2011cited by this paper
• Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma

  2011cited by this paper
• The three M’s: melanoma, microphthalmia‐associated transcription factor and microRNA

  2011cited by this paper
• Biology and clinical relevance of the micropthalmia family of transcription factors in human cancer.

  2011cited by this paper
• Inhibition of mutated, activated BRAF in metastatic melanoma.

  2010cited by this paper
• The ocular albinism type 1 (OA1) G-protein-coupled receptor functions with MART-1 at early stages of melanogenesis to control melanosome identity and composition.

  2009cited by this paper
• Multidrug resistance decreases with mutations of melanosomal regulatory genes.

  2009cited by this paper
• Integrative Analysis of Epigenetic Modulation in Melanoma Cell Response to Decitabine: Clinical Implications

  2009cited by this paper
• Influence of melanosome dynamics on melanoma drug sensitivity.

  2009cited by this paper
• Oncogenic NRAS has multiple effects on the malignant phenotype of human melanoma cells cultured in vitro

  2009cited by this paper
• The ocular albinism type 1 protein, an intracellular G protein-coupled receptor, regulates melanosome transport in pigment cells

  2008cited by this paper
• Targeting vesicle trafficking: an important approach to cancer chemotherapy.

  2008cited by this paper
• Novel MITF targets identified using a two‐step DNA microarray strategy

  2008cited by this paper
• Microphthalmia-Associated Transcription Factor Gene Amplification in Metastatic Melanoma Is a Prognostic Marker for Patient Survival, But Not a Predictive Marker for Chemosensitivity and Chemotherapy Response

  2007cited by this paper
• Melanosomes — dark organelles enlighten endosomal membrane transport

  2007cited by this paper
• Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas.

  2006cited by this paper
• Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma

  2005cited by this paper

• Chemo‐small extracellular vesicles released in cisplatin‐resistance ovarian cancer cells are regulated by the lysosomal function

  2024cites this paper
• The Keratinocyte in the Picture Cutaneous Melanoma Microenvironment

  2024cites this paper
• Chemo-sEVs release in cisplatin-resistance ovarian cancer cells are regulated by the lysosomal function

  2023cites this paper
• Pharmacological attenuation of melanoma by tryptanthrin pertains to the suppression of MITF-M through MEK/ERK signaling axis

  2022cites this paper
• Targeting Genome Stability in Melanoma—A New Approach to an Old Field

  2021cites this paper
• Amyloid aggregates accumulate in melanoma metastasis modulating YAP activity

  2020cites this paper
• Hitting the right targets : a study of molecular mediators of sensitivity to novel potential targeted therapies in cutaneous malignant melanoma

  2020cites this paper
• MITF is a driver oncogene and potential therapeutic target in kidney angiomyolipoma tumors through transcriptional regulation of CYR61

  2020cites this paper
• Immunometabolic Network Interactions of the Kynurenine Pathway in Cutaneous Malignant Melanoma

  2020cites this paper
• Growth Hormone Upregulates Melanocyte-Inducing Transcription Factor Expression and Activity via JAK2-STAT5 and SRC Signaling in GH Receptor-Positive Human Melanoma

  2019cites this paper
• GPCRs show widespread differential mRNA expression and frequent mutation and copy number variation in solid tumors

  2019cites this paper
• Melanosome maturation proteins Oca2, Mitfa and Vps11 are differentially required for cisplatin resistance in zebrafish melanocytes

  2019cites this paper
• Long non-coding RNA expression identified by microarray analysis: Candidate biomarkers in human acral lentiginous melanoma

  2019cites this paper
• Genome-wide characterization of copy number variations in diffuse large B-cell lymphoma with implications in targeted therapy

  2019cites this paper
• Proteomic analysis of Tn-bearing glycoproteins from different stages of melanoma cells reveals new biomarkers.

  2018cites this paper
• Oxidative stress and antioxidants in the pathophysiology of malignant melanoma

  2018cites this paper
• Insights from zebrafish on human pigment cell disease and treatment

  2017cites this paper
• Unravelling molecular mechanisms underlying therapy resistance in cutaneous melanoma

  2016cites this paper
• Nanoparticle-mediated drug delivery for treating melanoma.

  2015cites this paper
• BRAF inhibitor resistance mediated by the AKT pathway in an oncogenic BRAF mouse melanoma model

  2015cites this paper
• Metastatic melanoma cells with BRAF G469A mutation: nab-paclitaxel better than vemurafenib?

  2015cites this paper
• Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant Melanoma

  2015cites this paper
• Proteomics analysis of melanoma metastases: association between S100A13 expression and chemotherapy resistance

  2014cites this paper
• Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma

  2014cites this paper
• Acid sphingomyelinase determines melanoma progression and metastatic behaviour via the microphtalmia-associated transcription factor signalling pathway

  2013cites this paper